Related references
Note: Only part of the references are listed.High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
Ibrahim E. Awad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel et al.
ANTIVIRAL RESEARCH (2022)
The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant
Dandan Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao et al.
NATURE (2022)
Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product
Malgorzata Kowalska et al.
SCIENTIFIC REPORTS (2022)
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction
Shijulal Nelson-Sathi et al.
BMC MOLECULAR AND CELL BIOLOGY (2022)
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Sven Ullrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
SARS-COV-2 Mpro conformational changes induced by covalently bound ligands
Glaucio Monteiro Ferreira et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States
Shihang Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F. N. Souza et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods
Priyanka Sharma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
Paulo R. S. Sanches et al.
JOURNAL OF VIRUS ERADICATION (2021)
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta et al.
JAMA INTERNAL MEDICINE (2021)
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro
Shiv Bharadwaj et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2
Saroj Kumar Panda et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy
Marta Giovanetti et al.
COMMUNICATIONS BIOLOGY (2021)
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
Chao Lu et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Emanuele Andreano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Sajjan Rajpoot et al.
DRUGS IN R&D (2021)
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant et al.
CELL AND BIOSCIENCE (2021)
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
Michael Barton et al.
ELIFE (2021)
Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem
Rodrigo Honorato et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
The Emerging Concern and Interest SARS-CoV-2 Variants
Edyta Janik et al.
PATHOGENS (2021)
SARS-COV-2 Mpro conformational changes induced by covalently bound ligands
Glaucio Monteiro Ferreira et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
Yanxiao Han et al.
ACS NANO (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
A Systematic Review of COVID-19 Epidemiology Based on Current Evidence
Minah Park et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Temporal dynamics in viral shedding and transmissibility of COVID-19
Xi He et al.
NATURE MEDICINE (2020)
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
Rolando Cannalire et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SARS-CoV-2 Main Protease: A Molecular Dynamics Study
Dimas Suarez et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2
Surid Mohammad Chowdhury et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
In-silico design of a potential inhibitor of SARS-CoV-2 S protein
Grijesh Jaiswal et al.
PLOS ONE (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19
Wenxin Xu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Computational Design of 25-mer Peptide Binders of SARS-CoV-2
Thassanai Sitthiyotha et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Genomic characterization of a novel SARS-CoV-2
Rozhgar A. Khailany et al.
GENE REPORTS (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
RNA-virus proteases counteracting host innate immunity
Jian Lei et al.
FEBS LETTERS (2017)
Structural insights into conformational stability of both wild-type and mutant EZH2 receptor
Imlimaong Aier et al.
SCIENTIFIC REPORTS (2016)
Peptide therapeutics: Targeting the undruggable space
Natia Tsomaia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
NCBI Viral Genomes Resource
J. Rodney Brister et al.
NUCLEIC ACIDS RESEARCH (2015)
PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides
Pierre Thevenet et al.
NUCLEIC ACIDS RESEARCH (2012)
Structural, Dynamic, and Chemical Characterization of a Novel S-Glycosylated Bacteriocin
Hariprasad Venugopal et al.
BIOCHEMISTRY (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin lactococcin G
Per Rogne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Structure and mechanism of action of the antimicrobial peptide piscidin
Sylvie Campagna et al.
BIOCHEMISTRY (2007)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to α-carbon cross-links:: Formation and reduction of α-thio-α-amino acid derivatives
KE Kawulka et al.
BIOCHEMISTRY (2004)
Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide
QS Du et al.
PEPTIDES (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
SWISS-MODEL: an automated protein homology-modeling server
T Schwede et al.
NUCLEIC ACIDS RESEARCH (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
K Katoh et al.
NUCLEIC ACIDS RESEARCH (2002)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)